PaxMedica Inc. Renames to Kuvatris Therapeutics, Cancels Common Stock
I'm PortAI, I can summarize articles.
PaxMedica Inc. has restructured its corporate identity, changing its name to Kuvatris Therapeutics, Inc. This follows a certificate of amendment by CEO Howard J. Weisman. The company has also filed a Form 15-12g with the SEC, ending its registration under Section 12(g) of the Securities and Exchange Act and suspending reporting obligations. Furthermore, it has declared its common stock held by the Depositary Trust Company as null and void, instructing its transfer agent to cancel these shares.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments